Ophthalmic Epidemiology and Biostatistics focuses on understanding the distribution, determinants, progression, and outcomes of eye diseases through population and clinical research. The session highlights study design, statistical methodology, real-world evidence, risk prediction, comparative effectiveness, population datasets, and quantitative approaches supporting evidence-based ophthalmic care.
Abstract Scope and Participation
Abstracts may include population studies, observational research, clinical datasets, statistical methods, outcomes research, risk modeling, health services research, and real-world evidence. Epidemiologists, biostatisticians, ophthalmologists, researchers, data scientists, and public-health professionals are encouraged to contribute.
Introduction : Glaucoma is the second most common cause of blindness with Primary Open-Angle Glaucoma (POAG) as one of the leading causes. Objective : To study the ocular and systemic associated…
Topic: This scoping review synthesizes existing evidence on the ocular health status of Homeless or Marginally Housed (HMH) adults, highlighting the prevalence of visual impairment, ocular…
Topic: We reviewed the use of Minimal Clinically Important Difference (MCID) or related terminology, as well as the analysis of clinical relevance in ophthalmology trials, both in study design and in…
Topic: We reviewed the use of minimal clinically important difference (MCID) or related terminology, as well as the analysis of clinical relevance in ophthalmology trials, both in study design and in…
Background: Uveitis pattern varies according to regional, demographic, and racial factors. Therefore, an epidemiological study of the distribution of uveitis in various regions in India is likely to…
Purpose: Demographic representation in Diabetic Retinopathy Clinical Research (DRCR) studies is understudied and impacts the generalizability of results. This research aims to determine if the DRCR…
Sessions are CPD-accredited by The CPD Group (UK) — one CPD credit for every hour of attendance.
Oral and poster slots for original Ophthalmic Epidemiology and Biostatistics work, reviewed by the scientific committee.
Meet ophthalmologists, vision scientists, and eye-care clinicians from around the world across three days.
Accepted abstracts are compiled into the conference proceedings and indexed in Scopus and Web of Science.
Plenary lectures from leading voices shaping Ophthalmic Epidemiology and Biostatistics research and practice.
Attend in person in Singapore or join virtually — same programme, same certificate.
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
The Ophthalmic Epidemiology and Biostatistics track is a dedicated stream within IOC 2027 covering the latest research, clinical innovation, and best practice in Ophthalmic Epidemiology and Biostatistics. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Ophthalmologists, optometrists, vision scientists, educators, doctoral students, and trainees with an interest in Ophthalmic Epidemiology and Biostatistics are all welcome — whether presenting or attending.
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Yes. IOC 2027 is a hybrid conference — attend the Ophthalmic Epidemiology and Biostatistics track in person in Singapore or join live online, with on-demand access afterward.
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.
